2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Sepsis Newborn: new trials by email Literature Review of Sepsis Newborn trials Research Report on Sepsis Newborn
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Vs Multi-strain Probiotics for Preterm Neonates Dextrose 10%, Lactobacillus Rhamnosus GG, Bifidobacterium BB-12, Lactobacillus paracasei, L casei-431, Streptococcus thermophilus TH-4 - Necrotizing Enterocolitis of Newborn, Sepsis Newborn | Phase 4 | Completed | Madiha, MPhil | 249 | 2023-05-15 | 2025-12-22 |
| The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis Smoflipid ® - Sepsis Newborn | Phase 4 | Completed | Mansoura University Children Hospital | 40 | 2016-02-01 | 2018-03-23 |
Neonatal Sepsis (2) · Premature Birth (1) · Sepsis (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Infant, Newborn, Diseases (2) · Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Systemic Inflammatory Response Syndrome (2) · Female Urogenital Diseases and Pregnancy Complications (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pregnancy Complications (1) · Sepsis (1) · Urogenital Diseases (1)
SMOFlipid (1)
Madiha, MPhil (1) · Mansoura University Children Hospital (1)
Egypt (1) · Pakistan (1)
Imran Masood, PhD (1) · Yahya M Wahba, MD (1)
PMID 12710654, PMID 15585684, PMID 16254497, PMID 16632649, PMID 19571170, PMID 20393276, PMID 20398379, PMID 22319539, PMID 22942104, PMID 23398476, PMID 25722954, PMID 26146621, PMID 26630252, PMID 28630687